9ENO image
Deposition Date 2024-03-13
Release Date 2025-07-16
Last Version Date 2025-07-16
Entry Detail
PDB ID:
9ENO
Title:
Crystal structure of ComplemEnT1.4 (CEnT1.4), an engineered photoenzyme for selective [2+2]-cycloadditions
Biological Source:
Source Organism:
Loligo vulgaris (Taxon ID: 6622)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.73 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Diisopropyl-fluorophosphatase
Chain IDs:A, B
Chain Length:330
Number of Molecules:2
Biological Source:Loligo vulgaris
Primary Citation
Photosensitizer Repositioning Affords an Enantiocomplementary Enzyme for [2 + 2]-Cycloadditions.
Angew.Chem.Int.Ed.Engl. ? e202503576 e202503576 (2025)
PMID: 40576080 DOI: 10.1002/anie.202503576

Abstact

The combination of genetic code expansion and directed evolution has recently given rise to enantioselective photoenzymes for [2 + 2]-cycloadditions of quinolone and indole derivatives. However, the enzymes reported to date only allow access to one enantiomeric series of the strained cyclobutane products. Here, guided by a crystal structure of our previously engineered enzyme EnT1.3, we show how judicious repositioning of the genetically programmed benzophenone photosensitizer affords an enantiocomplementary [2 + 2]-cyclase, CEnT1.0. Following directed evolution, a proficient and oxygen-tolerant photoenzyme (CEnT1.4) emerged that promotes [2 + 2]-cycloadditions of a quinolone derivative with exquisite enantiocontrol (99% e.e.) and substantially enhanced regioselectivity compared with EnT1.3 (r.r. 62:1 vs. 9:1). Structural analysis of CEnT1.4, coupled with molecular dynamic simulations, reveals a well-sculpted active site pocket that pre-organises the substrate for regio- and enantioselective catalysis. This study highlights the versatility offered by genetically programmed (photo)catalytic elements when developing enzymes for altered stereochemical outcomes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures